Compare Charles River Laboratories vs Receptos
Customers evaluate the quality of Charles River Laboratories's products using the following success metrics.
Overview
Charles River Laboratories is 77 yrs old and is based in United States.
Charles River Laboratories (NYSE: CRL) provides clinical tests and drug development services. It offers test and development services for vaccines, biosimilars, and medicine to treat the cardiovascular, skeletal, endocrine, central nervous system, cancer, and other sorts of ailments. The company was founded in 1947 and is based in Wilmington, Massachusetts.
Receptos is based in United States
Receptos (NASDAQ: RCPT) is a biopharmaceutical company focused on discovering, developing and commercializing innovative therapeutics in immune disease. The company's lead asset, RPC1063, is being developed as an oral therapy for Relapsing Multiple Sclerosis (RMS) and Inflammatory Bowel Disease (IBD). The goal of the company's development strategy for RPC1063 is to demonstrate clinically meaningful differentiation versus other available treatments, including a favorable safety profile.
Demo Video
Leadership
Birgit Girshick (Executive Vice President)
Hugh Rosen (Founder)
Product
Benefits
Products
Customers
Known Partners
Why They Buy
Information not available because Charles River Laboratories has not claimed their profile.
Work for Charles River Laboratories? Claim your profile by submitting an Analyst Briefing. By submitting you can
Work for Charles River Laboratories?
Claim your profile now.
Information not available because Receptos has not claimed their profile.
Work for Receptos? Claim your profile by submitting an Analyst Briefing. By submitting you can
Work for Receptos?
Claim your profile now.